Drew Ranieri

Stock Analyst at Morgan Stanley

(1.26)
# 3,426
Out of 4,853 analysts
164
Total ratings
44.94%
Success rate
-12.33%
Average return

Stocks Rated by Drew Ranieri

Organogenesis Holdings
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $4$6
Current: $2.97
Upside: +102.02%
Globus Medical
Dec 2, 2024
Upgrades: Overweight
Price Target: $83$100
Current: $59.58
Upside: +67.84%
Stryker
Dec 2, 2024
Upgrades: Overweight
Price Target: $370$445
Current: $384.38
Upside: +15.77%
SI-BONE
Aug 6, 2024
Maintains: Overweight
Price Target: $21$19
Current: $18.69
Upside: +1.66%
Integra LifeSciences Holdings
Jul 15, 2024
Maintains: Underweight
Price Target: $24$27
Current: $13.43
Upside: +101.04%
Treace Medical Concepts
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $5.5$8
Current: $5.85
Upside: +36.75%
Stevanato Group
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $26$22
Current: $23.00
Upside: -4.35%
NeuroPace
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $9.5$8
Current: $13.37
Upside: -40.16%
Alphatec Holdings
Jul 15, 2024
Maintains: Overweight
Price Target: $19$16
Current: $12.54
Upside: +27.59%
Outset Medical
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $75$83
Current: $19.80
Upside: +316.67%
Maintains: Overweight
Price Target: $42$38
Current: $18.74
Upside: +102.77%
Maintains: Equal-Weight
Price Target: $88$96
Current: $70.07
Upside: +37.01%
Maintains: Underweight
Price Target: $28$26
Current: $12.41
Upside: +109.51%
Maintains: Overweight
Price Target: $290$295
Current: $172.46
Upside: +71.05%
Maintains: Equal-Weight
Price Target: $236$280
Current: $123.67
Upside: +126.41%
Maintains: Overweight
Price Target: $11$5
Current: $6.51
Upside: -23.20%
Maintains: Overweight
Price Target: $72$70
Current: $30.25
Upside: +131.40%
Maintains: Equal-Weight
Price Target: $325$300
Current: $563.55
Upside: -46.77%